Voltaren® Gel: First US FDA Approved Topical Treatment for OA-Related Pain
The recent approval of Voltaren® Gel makes it the first USFDA –approved prescription NSAID (non-steroidal anti- inflammatory drug) treatment that can be applied directly to site of osteoarthritis pain.
Voltaren® Gel is the only prescription topical medication proven to significantly reduce osteoarthritis pain in both the knees and the joints of the hand that offers highly effective pain relief with minimal drug absorption throughout the body - shown to be 94% less than comparable oral diclofenac treatment.
